Biomea Fusion (BMEA) Stock Price

$3.46 0%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    4

  • Fundamental

    1

  • Technical

    2

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Biomea Fusion, AI stock picks, stock alerts and much more.

Sign up

BMEA AI Stock Analysis

AI stock analysis for BMEA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Biomea Fusion (BMEA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Biomea Fusion (BMEA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Biomea Fusion (BMEA), currently trading at $3.46, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About BMEA

LSE

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
INO Inovio Pharmaceuticals
INO		 $2.24
0.9%
2
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6

News

Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?

Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?
December 17, 2024. benzinga.com
Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes

Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes
December 17, 2024. globenewswire.com
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)

Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
December 16, 2024. globenewswire.com
Biomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

Biomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
December 12, 2024. globenewswire.com

BMEA Alternative Data

Web Traffic

Biomea Fusion receives an estimated 12500 monthly visitors to biomeafusion.com.

  • Web Traffic

    12500

  • Change from Previous Month

    26.1%

  • 3 Month Change

    39.5%

  • YoY Change

    39.5%

News Mentions

Biomea Fusion was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

Biomea Fusion has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Facebook Engagement

Biomea Fusion has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

  • YoY Change

    100%

Youtube Subscribers

Biomea Fusion has 130 subscribers on its main Youtube channel, down by -1.5% over the last month.

  • Youtube Subscribers

    130

  • Daily Change

    0%

  • 1 Month Change

    1.5%

  • 3 Month Change

    8.3%

  • YoY Change

    8.3%

LinkedIn Followers

5,578 are following Biomea Fusion on LinkedIn, up by 2.3% over the last month.

  • LinkedIn Followers

    5578

  • Daily Change

    0.1%

  • 1 Month Change

    2.3%

  • 3 Month Change

    8.3%

Job Postings

Biomea Fusion has an estimated 3 open job postings, which is down -66.7% over the last month.

  • Job Postings

    3

  • Daily Change

    25%

  • 1 Month Change

    66.7%

  • 3 Month Change

    40%

  • YoY Change

    40%

LinkedIn Employees

According to LinkedIn, Biomea Fusion has 99 employees.

  • LinkedIn Employees

    99

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    1%

  • YoY Change

    1%

Twitter Followers

Biomea Fusion has 8,003 Twitter Followers on its main Twitter (also known as X) account, which is down by -2.8% over the last month.

  • Twitter Followers

    8003

  • Daily Change

    0.3%

  • 1 Month Change

    2.8%

  • 3 Month Change

    8.8%

  • YoY Change

    8.8%

Instagram Followers

Biomea Fusion has 4,824 Instagram Followers on its main Instagram account, up by 0.5% over the last month.

  • Instagram Followers

    4824

  • Daily Change

    0.3%

  • 1 Month Change

    0.5%

  • 3 Month Change

    0.5%

  • YoY Change

    0.5%

Business Outlook

  • Business Outlook

    65

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

BMEA Financials

BMEA Key Metrics

  • Total Revenue

    $0

  • Net Income

    -$32.8M

  • Earnings per Share

    -$0.91

  • Free cash flow

    -$25.4M

  • EBITDA

    -$34M

  • EBITDA Ratio

    0

  • Total Assets

    $110.4M

BMEA 2-year Revenue & Income
BMEA 2-year Free Cash Flow

BMEA Technicals

BMEA SMA
BMEA RSI

FAQ

What's the current price of Biomea Fusion (BMEA) Stock?
The price of an Biomea Fusion (BMEA) share is $3.46.

What's the market cap of Biomea Fusion?
The current market cap of Biomea Fusion is 125.4M.

Should I buy or sell BMEA?
Biomea Fusion exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Biomea Fusion a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Biomea Fusion stock. There are several bearish signals and market challenges that could negatively impact Biomea Fusion's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Biomea Fusion (BMEA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Biomea Fusion stock right now, as the outlook appears bearish.

What are some stocks similar to Biomea Fusion (BMEA) that investors often compare it to?
Biomea Fusion (BMEA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Biomea Fusion's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Biomea Fusion's stock price to be around $3.13 in 2026. Starting from the current price of $3.46, this represents a 9.6% change in price, indicating a bearish outlook for the stock.

How to buy Biomea Fusion (BMEA) Stock?
Biomea Fusion stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Biomea Fusion shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.